SMARCA1 and carcinoma: Assessing the SWI/SNF chromatin remodeling complex has facilitated the classification and development of therapeutic strategies for various soft tissue tumors, carcinomas, and adenocarcinomas affecting organs such as the lungs, genitourinary tract, gastrointestinal tract, central nervous system, nasal cavity, and paranasal sinuses [3,4,11].